Cart summary

You have no items in your shopping cart.

IRX5010

SKU: orb2944854

Description

IRX5010 (IRX4647F) is a potent and selective RARγ agonist. It demonstrates efficacy in inhibiting the growth of EMT-6 triple-negative breast cancer cells in vitro and has shown antitumor activity in relevant in vivo model studies.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number856683-59-5
MW395.466
FormulaC24H26FNO3
SMILESCC1(C)C=2C(=CC=C(\C(\C=C\C3=C(F)C=C(C(O)=O)C=C3)=N\O)C2)C(C)(C)CC1
TargetRetinoid Receptor,RAR/RXR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

IRX5010 (orb2944854)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%